Biogen (BIIB) Other Non-Current Liabilities (2009 - 2026)
Biogen (BIIB) recorded Other Non-Current Liabilities of $820.9 million in Q2 2026, up 2.7% from $799.6 million a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen reported Other Non-Current Liabilities of $748.5 million, up 2.2% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -10.9% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $732.3 million in FY2024 (-6.2%), $781.1 million in FY2023 (-17.3%), $944.2 million in FY2022 (-28.5%) and $1.32 billion in FY2021 (-0.7%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities since Q1 2023.
- On a year-over-year basis, Other Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 5.7% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 43.6% in Q2 2025, against a decline of 37.6% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $787.1 million (Q1 2026), $748.5 million (Q4 2025) and $761.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 820.90 Mn |
| Mar 31, 2026 | 787.10 Mn |
| Dec 31, 2025 | 748.50 Mn |
| Sep 30, 2025 | 761.80 Mn |
| Jun 30, 2025 | 799.60 Mn |
| Mar 31, 2025 | 751.70 Mn |
| Dec 31, 2024 | 732.30 Mn |
| Sep 30, 2024 | 744.10 Mn |
| Jun 30, 2024 | 556.70 Mn |
| Mar 31, 2024 | 777.10 Mn |
| Dec 31, 2023 | 781.10 Mn |
| Sep 30, 2023 | 747.90 Mn |
| Jun 30, 2023 | 776.90 Mn |
| Mar 31, 2023 | 935.50 Mn |
| Dec 31, 2022 | 944.20 Mn |
| Sep 30, 2022 | 1.20 Bn |
| Jun 30, 2022 | 1.17 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.32 Bn |
| Sep 30, 2021 | 1.32 Bn |
API Access
Biogen Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();